Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
In vitro autoradiographic localization of amylin binding sites in rat brain
Safety Comparison Table# Research Evidence Comparison# MariTide Research# MariTide's key evidence comes from a phase 2 trial published in the New England Journal of Medicine (2025): Design: 592 participants across two cohorts -- obesity without T2D, and obesity with T2D -- over 52 weeks Obesity cohort: Mean weight loss ranged from -12.3% to -16.2% with MariTide vs -2.5% with placebo (up to 20% in some analyses) Obesity + T2D cohort: Mean weight loss ranged from -8.4% to -12.3% with MariTide vs -1.7% with placebo
4eh), we compared ATP levels in Gclc fl/fl and Gclc fl/fl Mb1-Cre + FoB prior to activation
Malla M, Loree JM, Kasi PM, Parikh AR
